Baker Mark Robert 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Mar 2, 2018
Insider Transaction Report
Form 4
Baker Mark Robert
General Counsel
Transactions
- Award
Non-Qualified Stock Option (Right to Buy)
2018-03-01+201,250→ 201,250 totalExercise: $6.62Exp: 2028-03-01→ Common Stock (201,250 underlying)
Footnotes (1)
- [F1]3yr 33% On Vest beginning on 01-Mar-2018